Similar articles for PMID: 30397707

Year	Number of Results
1987	2
1988	1
1989	3
1990	4
1992	2
1993	1
1994	1
1995	1
1997	2
1998	1
1999	1
2000	1
2001	2
2002	2
2004	1
2005	2
2006	1
2007	2
2008	4
2009	4
2010	2
2011	1
2012	1
2013	10
2014	9
2015	10
2016	2
2017	8
2018	7
2019	6
2020	6
2021	5
2022	6
2023	3
2024	1

1

Clinical efficacy of low dose recombinant tissue-type plasminogen activator for the treatment of acute intermediate-risk pulmonary embolism.

Zhang LY, Gao BA, Jin Z, Xiang GM, Gong Z, Zhang TT, Lu HF, Wang YQ, Gong Y, Lu C, Huang WL. Zhang LY, et al. Saudi Med J. 2018 Nov;39(11):1090-1095. doi: 10.15537/smj.2018.11.22717. Saudi Med J. 2018. PMID: 30397707 Free PMC article. Clinical Trial.

2

Low-dose thrombolysis for submassive pulmonary embolism.

Yilmaz ES, Uzun O. Yilmaz ES, et al. J Investig Med. 2021 Dec;69(8):1439-1446. doi: 10.1136/jim-2021-001816. Epub 2021 Jun 7. J Investig Med. 2021. PMID: 34099544 Free PMC article.

3

Randomized, controlled trial of ultrasound-assisted catheter-directed thrombolysis for acute intermediate-risk pulmonary embolism.

Kucher N, Boekstegers P, Müller OJ, Kupatt C, Beyer-Westendorf J, Heitzer T, Tebbe U, Horstkotte J, Müller R, Blessing E, Greif M, Lange P, Hoffmann RT, Werth S, Barmeyer A, Härtel D, Grünwald H, Empen K, Baumgartner I. Kucher N, et al. Circulation. 2014 Jan 28;129(4):479-86. doi: 10.1161/CIRCULATIONAHA.113.005544. Epub 2013 Nov 13. Circulation. 2014. PMID: 24226805 Clinical Trial.

4

Clinical safety and efficacy of thrombolytic therapy with low-dose prolonged infusion of tissue type plasminogen activator in patients with intermediate-high risk pulmonary embolism.

Güner A, Kalçik M, Aykan AÇ, Gürsoy MO, Kalkan AK, Astarcioğlu MA, Ertürk M, Uzun F, Güner EG, Yildiz M, Özkan M. Güner A, et al. Blood Coagul Fibrinolysis. 2020 Dec;31(8):536-542. doi: 10.1097/MBC.0000000000000960. Blood Coagul Fibrinolysis. 2020. PMID: 33181758

5

Retrospective comparison of ultrasound facilitated catheter-directed thrombolysis and systemically administered half-dose thrombolysis in treatment of pulmonary embolism.

Sharifi M, Awdisho A, Schroeder B, Jiménez J, Iyer P, Bay C. Sharifi M, et al. Vasc Med. 2019 Apr;24(2):103-109. doi: 10.1177/1358863X18824159. Epub 2019 Mar 5. Vasc Med. 2019. PMID: 30834822

6

Comparative Efficacy and Safety of Thrombolytic Agents for Pulmonary Embolism: A Bayesian Network Meta-Analysis.

Li HY, Wang YB, Ren XY, Wang J, Wang HS, Jin YH. Li HY, et al. Pharmacology. 2023;108(2):111-126. doi: 10.1159/000527668. Epub 2023 Jan 5. Pharmacology. 2023. PMID: 36603558 Free PMC article.

7

Ultrasound-accelerated catheter-directed thrombolysis for acute submassive pulmonary embolism.

Bagla S, Smirniotopoulos JB, van Breda A, Sheridan MJ, Sterling KM. Bagla S, et al. J Vasc Interv Radiol. 2015 Jul;26(7):1001-6. doi: 10.1016/j.jvir.2014.12.017. Epub 2015 Feb 18. J Vasc Interv Radiol. 2015. PMID: 25704224

8

Thrombolysis with reteplase in acute pulmonary embolism.

Nishanth KR, Math RS, Shankar M, Ravindranath KS, Manjunath CN. Nishanth KR, et al. Indian Heart J. 2019 Nov-Dec;71(6):464-467. doi: 10.1016/j.ihj.2019.09.011. Epub 2019 Sep 20. Indian Heart J. 2019. PMID: 32248919 Free PMC article.

9

A Prospective, Single-Arm, Multicenter Trial of Ultrasound-Facilitated, Catheter-Directed, Low-Dose Fibrinolysis for Acute Massive and Submassive Pulmonary Embolism: The SEATTLE II Study.

Piazza G, Hohlfelder B, Jaff MR, Ouriel K, Engelhardt TC, Sterling KM, Jones NJ, Gurley JC, Bhatheja R, Kennedy RJ, Goswami N, Natarajan K, Rundback J, Sadiq IR, Liu SK, Bhalla N, Raja ML, Weinstock BS, Cynamon J, Elmasri FF, Garcia MJ, Kumar M, Ayerdi J, Soukas P, Kuo W, Liu PY, Goldhaber SZ; SEATTLE II Investigators. Piazza G, et al. JACC Cardiovasc Interv. 2015 Aug 24;8(10):1382-1392. doi: 10.1016/j.jcin.2015.04.020. JACC Cardiovasc Interv. 2015. PMID: 26315743 Free article. Clinical Trial.

10

Catheter-directed therapies for the treatment of high risk (massive) and intermediate risk (submassive) acute pulmonary embolism.

Harvey JJ, Huang S, Uberoi R. Harvey JJ, et al. Cochrane Database Syst Rev. 2022 Aug 8;8(8):CD013083. doi: 10.1002/14651858.CD013083.pub2. Cochrane Database Syst Rev. 2022. PMID: 35938605 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

101 results

Results by year